Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from GSK

You Can Stop Looking, Here's the Perfect Stock for the Current Market

While technology stocks continue to struggle, stocks in the lucrative over-the-counter healthcare products sector are thriving. One prominent such name is Haleon. Its stock has jumped more than 22% over the past three months, as sales and profits in its nine large-scale multinational, high-margin 'power brands' continue to hold leading…

Barchart · Sep 4, 2024

CDC issues new guidelines for RSV vaccines, citing side-effect concerns

The CDC has clarified and narrowed its recommendations for which older adults should get an RSV vaccine.

LiveScience · Aug 6, 2024

GSK’s health is improving. Shame about the legal heartburn

Emma Walmsley’s overhaul seems to be delivering the goods even if US worries have left the share price becalmed

The Guardian - UK · Jul 31, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

XDefiant Factions Guide: Everything You Need To Know

This XDefiant factions guide helps players know what the different factions specialize in and what abilities they provide during combat.

Player One · Jul 29, 2024

Bird flu isn’t spreading in humans for now. But there are vaccines in the pipeline if that changes

Since May, a number of poultry farms around Australia have faced outbreaks of avian influenza, or bird flu. These outbreaks have been devastating for the poultry farms affected, necessitating large-scale culls, and have caused knock-on effects for the country’s egg supplies.

The Conversation · Jul 16, 2024

A 'new era' in malaria control has begun with a vaccination campaign for children in Ivory Coast

Health workers in Ivory Coast have begun giving children the latest malaria vaccine

The Independent UK · Jul 15, 2024

US service sector shrinks for first time since May 2020; UK private sector growth slows in ‘pre-election seize up’ – as it happened

Eurozone private sector also loses momentum

The Guardian - UK · Jul 3, 2024

Read news from The Economist, FT, and more,
with one subscription

Can I take antihistamines everyday? More than the recommended dose? What if I’m pregnant? Here’s what the research says

Allergies happen when your immune system overreacts to a normally harmless substance like dust or pollen. Hay fever, hives and anaphylaxis are all types of allergic reactions.

The Conversation · Jun 27, 2024

As big pharma exits Nigeria, asthma patients face spiralling costs

Price of asthma inhalers has more than doubled amid scarcity and added costs after GSK exited Nigerian market in 2023.

Al Jazeera · Jun 19, 2024

New RSV shots tied to rare nervous system disorder — should you worry?

There's been some reports of Guillain-Barré syndrome in older adults who got the vaccines. But health officials still recommend that this population get the shots, in consultation with their doctors.

LiveScience · Jun 13, 2024

3 Value Stocks to Buy for Bargain Hunters

Amid macroeconomic challenges like high inflation, recession threats, and global uncertainties, value stocks such as GSK (GSK), Expedia Group (EXPE), and Albertsons (ACI) offer promising opportunities for savvy bargain hunters. Read on.

StockNews.com · Jun 12, 2024

FTSE 100 Live 3 June: New York trading glitch sparks volatility, GSK shares tumble

BP and Shell shares today hindered FTSE 100 progress after oil prices fell to their lowest level since February.

Evening Standard · Jun 3, 2024

Guillain-Barre Syndrome 'More Common Than Expected' In RSV Vaccinated Older Adults: CDC

While the U.S. Food and Drug Administration (FDA) and the officials from the CDC continue to investigate the risks, the current recommendation is to continue the vaccine as "the estimated benefits of RSV vaccination continued to outweigh potential risks."

Medical Daily · May 31, 2024

Top 4 Pharma Stocks for Long-Term Value Investors in 2024

The pharmaceutical sector is experiencing rapid growth thanks to the rising demand for precision drugs, the growing geriatric population, and an uptick in chronic diseases. Given this backdrop, long-term value investors could consider buying and holding quality pharmaceutical stocks such as Organon (OGN), Procaps (PROC), Johnson & Johnson (JNJ), and…

StockNews.com · May 27, 2024

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard · May 17, 2024

FTSE 100 Live 17 May: LandSec shares fall on results, GSK in £1.25bn final Haleon stake sale

GSK and Land Securities are in the FTSE 100 spotlight after the drugs giant sold its final Haleon shares and the property firm posted results.

The Guardian - UK · May 11, 2024

‘The issue is when to pull the trigger’: how prepared are we for human bird flu?

The H5N1 virus has been devastating bird populations, and is now infecting mammals too. Is human-to-human transmission next? And are we ready for another pandemic?

WEKU · May 6, 2024

Could better asthma inhalers help patients, and the planet too?

Some doctors are promoting propellant-free inhalers over puff inhalers that emit greenhouse gases. Climate change can exacerbate respiratory ills because of more fires, air pollution and allergens.

StockNews.com · May 1, 2024

The pharmaceutical industry is set for solid growth due to increased demand for effective treatments for regular and rare diseases, an aging population, and ongoing innovations in pharma technology. Hence, investors could consider buying quality pharmaceutical stocks such as Collegium Pharmaceutical (COLL), Novo Nordisk (NVO), and GSK (GSK). Read on.

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard · May 1, 2024

FTSE 100 Live 1 May: US Fed notes ‘lack of further progress’ on inflation as it holds interest rates

Forecast-beating results by Shell and Standard Chartered today boosted their shares during another robust session for the FTSE 100 index.

Top News · Apr 18, 2024

Asthma Medication Shortage Puts Children At Risk

Families face challenges in affording essential asthma medication for children due to high costs and limited insurance coverage, highlighting the need for ...

International Business Times · Apr 4, 2024

Sanofi To Settle Around 4,000 Suits Over Zantac Cancer Allegations

Sanofi will settle around 4,000 claims alleging its heartburn medication, Zantac, is linked to cancer.

StockNews.com · Mar 18, 2024

3 Pharma Stocks Fueling Investor Enthusiasm

The pharmaceutical industry is expected to expand rapidly due to growing global healthcare needs and advancements in technology. Therefore, fundamentally strong pharma stocks Merck (MRK), AbbVie (ABBV), and GSK plc (GSK) might be ideal additions to your portfolio. Read on.

Barchart · Mar 2, 2024

Beyond the GRANOLAS: JPMorgan Picks 3 Top Stocks to Bet on Europe

The renowned brokerage firm weighed in on its top stock picks from the European market, which could offer investors better value than the outsized GRANOLAS group of equities at current levels.

The Guardian - UK · Mar 2, 2024

‘It feels like we’ve been lobotomised’: the possible sexual consequences of SSRIs

Long-term sexual dysfunction is a side-effect for some patients who take these widely prescribed antidepressants, and can leave sufferers devastated

The Guardian - UK · Mar 1, 2024

GlaxoSmithKline boss’s pay package jumps 50% to £12.7m

Emma Walmsley’s deal, with a high share bonus payout, makes her one of top-paid CEOs in FTSE 100

1 … 7 8 9 10

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.